Mucus Perspective to Conduct the Molecular Concertation in Inflammatory Bowel Diseases
Preprint
- 30 May 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
The inflammatory bowels diseases (IBD) are autoimmune diseases that deeply impact the patients’ quality of life. The IBD pathogenesis is not yet defined, but evidence demonstrated that the IBD chronic inflammation is related to an impaired intestinal barrier. Traditionally, two actors were considered for their contribution to this disfunction: the gut microbiota and intestinal epithelium. However, a third element, which is the intestinal mucus, should be considered as peer of the epithelium and microbiota. Indeed, mucus represents the biological interface between bacteria and cells, filtering molecules or toxins and preventing bacteria penetration exploiting both structural and compositional properties. The boosting effect of the mucus characterization towards IBD comprehension is far too underestimated, although some mucus-oriented studies are already reported in literature. This work reviews the intestinal barrier features, describing each component of the gut mucosa (i.e., epithelium, microbiota, and mucus) in a mucus-oriented perspective.Keywords
All Related Versions
This publication has 137 references indexed in Scilit:
- Heterogeneity Governs 3D‐Cultures of Clinically Relevant Microbial CommunitiesAdvanced Functional Materials, 2023
- Gastrointestinal consequences of lipopolysaccharide-induced lung inflammationInflammation Research, 2022
- Mucosomes: Intrinsically Mucoadhesive Glycosylated Mucin Nanoparticles as Multi‐Drug Delivery PlatformAdvanced Healthcare Materials, 2022
- Classification of Inflammatory Bowel Disease in Children2017
- Altered O-glycosylation profile of MUC2 mucin occurs in active ulcerative colitis and is associated with increased inflammationInflammatory Bowel Diseases, 2011
- Lipopolysaccharide exposure is linked to activation of the acute phase response and growth failure in pediatric Crohnʼs disease and murine colitisInflammatory Bowel Diseases, 2010
- Alterations of phospholipid concentration and species composition of the intestinal mucus barrier in ulcerative colitis: A clue to pathogenesisInflammatory Bowel Diseases, 2009
- Epidemiology of Clostridium difficile Colitis in Hospitalized Patients with Inflammatory Bowel DiseasesDiseases of the Colon & Rectum, 2009
- Mucin abnormality of colonic mucosa in ulcerative colitis associated with carcinoma and/or dysplasiaDiseases of the Colon & Rectum, 1988
- Hydrophobic Interactions: Role in Bacterial Adhesion1986